HK1061244A1 - Tricyclic derivatives of indole with antiangiogenic activity - Google Patents

Tricyclic derivatives of indole with antiangiogenic activity

Info

Publication number
HK1061244A1
HK1061244A1 HK04104343A HK04104343A HK1061244A1 HK 1061244 A1 HK1061244 A1 HK 1061244A1 HK 04104343 A HK04104343 A HK 04104343A HK 04104343 A HK04104343 A HK 04104343A HK 1061244 A1 HK1061244 A1 HK 1061244A1
Authority
HK
Hong Kong
Prior art keywords
indole
antiangiogenic activity
tricyclic derivatives
tricyclic
derivatives
Prior art date
Application number
HK04104343A
Other languages
English (en)
Inventor
Giuseppe Giannini
Mauro Marzi
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1061244A1 publication Critical patent/HK1061244A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04104343A 2000-11-03 2004-06-16 Tricyclic derivatives of indole with antiangiogenic activity HK1061244A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000570A IT1317926B1 (it) 2000-11-03 2000-11-03 Derivati triciclici dell'indolo ad attivita' antiangiogenica.
PCT/IT2001/000526 WO2002036597A1 (en) 2000-11-03 2001-10-16 Tricyclic derivatives of indole with antiangiogenic activity

Publications (1)

Publication Number Publication Date
HK1061244A1 true HK1061244A1 (en) 2004-09-10

Family

ID=11454976

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04104343A HK1061244A1 (en) 2000-11-03 2004-06-16 Tricyclic derivatives of indole with antiangiogenic activity

Country Status (20)

Country Link
US (2) US6887892B2 (zh)
EP (1) EP1343789B1 (zh)
JP (1) JP2004513130A (zh)
KR (1) KR20030042030A (zh)
CN (1) CN1247589C (zh)
AT (1) ATE302780T1 (zh)
AU (1) AU1518602A (zh)
BR (1) BR0115119A (zh)
CA (1) CA2427568A1 (zh)
CZ (1) CZ297299B6 (zh)
DE (1) DE60112966T2 (zh)
DK (1) DK1343789T3 (zh)
ES (1) ES2247182T3 (zh)
HK (1) HK1061244A1 (zh)
HU (1) HUP0400546A3 (zh)
IT (1) IT1317926B1 (zh)
MX (1) MXPA03003798A (zh)
PL (1) PL364908A1 (zh)
SK (1) SK5342003A3 (zh)
WO (1) WO2002036597A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849656B1 (en) 1999-09-17 2005-02-01 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
US7528165B2 (en) 2001-12-13 2009-05-05 National Health Research Institutes Indole compounds
US7632955B2 (en) 2001-12-13 2009-12-15 National Health Research Institutes Indole compounds
US6800655B2 (en) 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
US7456289B2 (en) 2004-12-31 2008-11-25 National Health Research Institutes Anti-tumor compounds
EP1856126A2 (en) * 2005-02-17 2007-11-21 Wyeth a Corporation of the State of Delaware Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
EP1852429B1 (de) * 2006-04-25 2010-09-15 Merck Patent GmbH Hexahydro-dibenzofuranderivate
FR2928645A1 (fr) * 2008-03-14 2009-09-18 Sanofi Aventis Sa Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
US20150210717A1 (en) * 2012-09-13 2015-07-30 Baden-Württemberg Stiftung Gmbh Specific inhibitors of protein p21 as therapeutic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds

Also Published As

Publication number Publication date
CN1247589C (zh) 2006-03-29
KR20030042030A (ko) 2003-05-27
US20040034052A1 (en) 2004-02-19
ITRM20000570A1 (it) 2002-05-03
JP2004513130A (ja) 2004-04-30
DK1343789T3 (da) 2005-12-27
CZ20031042A3 (cs) 2003-10-15
ITRM20000570A0 (it) 2000-11-03
DE60112966D1 (de) 2005-09-29
CZ297299B6 (cs) 2006-11-15
HUP0400546A2 (hu) 2004-06-28
SK5342003A3 (en) 2003-10-07
HUP0400546A3 (en) 2007-08-28
MXPA03003798A (es) 2004-04-20
IT1317926B1 (it) 2003-07-15
EP1343789A1 (en) 2003-09-17
ES2247182T3 (es) 2006-03-01
WO2002036597A1 (en) 2002-05-10
ATE302780T1 (de) 2005-09-15
US6887892B2 (en) 2005-05-03
AU1518602A (en) 2002-05-15
CA2427568A1 (en) 2002-05-10
US20050124647A1 (en) 2005-06-09
CN1471535A (zh) 2004-01-28
PL364908A1 (en) 2004-12-27
DE60112966T2 (de) 2006-05-24
EP1343789B1 (en) 2005-08-24
BR0115119A (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
TR200003206T2 (tr) İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları.
MY125942A (en) Aminoalkoxy carbazoles for the treatment of cns diseases
AU9102198A (en) Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
SG148834A1 (en) Compounds for the modulation of ppary activity
BG105270A (en) Tetrahydropyridoethers
HK1061244A1 (en) Tricyclic derivatives of indole with antiangiogenic activity
MXPA02009552A (es) Derivados de imidazopiridina alquilada.
TR200001687T2 (tr) Neopleasyo için N-benzil-3-indenilasetamid türevleri.
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
IL150329A0 (en) 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
GB2378948B (en) Novel compounds for modulating cell proliferation
HK1055304A1 (en) Tricyclic imidazopyridines
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
AP2001002045A0 (en) FKBP inhibitors.
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
MXPA04001048A (es) Imidazopiridinas sustituidas con alquilo, para el tratamiento de trastornos gastrointestinales.
IT1314187B1 (it) Combinazione di differenti composizioni farmaceutiche per iltrattamento del carcinoma mammario e relativo uso
EP1894569A3 (en) Tetracycline derivatives for treating cancer
UA36367A (uk) Кальцію сукцинат, що має кардіотонічну дію
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091016